SecBot SecBot

ZDAI

DirectBooking Technology Co., Ltd.
Nasdaq· General Bldg Contractors - Nonresidential Bldgs· Inc. E9· CIK 0001966678 Industrials & Manufacturing
$1.26 −0.05 (−3.75%)
Oct 26 4:00 PM ET · prev $1.31
Market cap
$10.7M
Nano cap
1 year
−84.7%
from $8.26 · Oct 27
30 days
−23.6%
from $1.65
52-week range
$1.20–11.20
−89% from high · low Oct 20
Avg volume 20D
7.8K
Oct 12 spike 41.8K
Short interest
24.7K
≈0.3% of shares · +19.4%
Days to cover
2.9
at average volume
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 2 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 3/3
Strongest BEARISH DirectBooking Technology (ZDAI) entered into a subscription agreement to issue 5,000,000 Class A ordinary…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersBUILDING

    Short interest +19.4% to 24.7K shares. 2.9 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    17% below its 50-day average. New closing low $1.20 on Oct 20.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
DirectBooking Technology (ZDAI) entered into a subscription agreement to issue 5,000,000 Class A ordinary shares at…
6-K — Impact 6/10
Aug 17, 2026 SEC
DirectBooking Technology (ZDAI) filed its FY2026 20-F, reporting revenue declined 53.6% YoY to $8.94M, a gross loss of…
20-F — Impact 7/10
Aug 11, 2026 SEC
DirectBooking Technology Co., Ltd. (ZDAI) terminated its Securities Purchase Agreement to acquire 49% of China Wangmao…
6-K — Impact 6/10
Apr 13, 2026 Event
LEVOFLOXACIN
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENT
Mar 26, 2026 Other
All Resolutions Passed at DirectBooking Technology Extraordinary General Meeting, Clearing Path for Enhanced Share Capital Structure
DirectBooking investors endorse six resolutions reshaping capital and voting control.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
24,686
shares short
+19.4%
vs prior settlement
2.9
days to cover
≈0.3%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Apr 13, 2026
FDA
LEVOFLOXACIN
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYA
Mar 26, 2026
Press release
All Resolutions Passed at DirectBooking Technology Extraordinary General Meeting, Clearing Path for Enhanced Share Capital Structure
DirectBooking investors endorse six resolutions reshaping capital and voting control.
Mar 6, 2026
Press release
DirectBooking Technology Co., Ltd. Announces Regained Compliance with Nasdaq Minimum Bid Price Requirement
DirectBooking Technology regained Nasdaq compliance as its stock closed at or above $1 for 10 straight days, resolving the prior bid-price deficiency.

SecBot reports

6 filings · 0 bullish · 2 bearish · 1 mixed · 3 neutral
All ZDAI filing & press-release reports (6)